Do antidepressants take more lives than they save?An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.
First-in-class therapy promising for Parkinson's disease psychosisA first-in-class antipsychotic that is a selective serotonin inverse agonist (with no dopaminergic, histaminergic, adrenergic, or muscarinic activity) potentially targeting 5-HT2A receptors, improved Parkinson’s disease psychosis (PDP) with demonstrated safety and tolerability, and without worsening motor Parkinson’s, according to data presented in two posters at the 19th International Congress of Parkinson’s Disease and Movement Disorders (MDS), in San Diego.
New research uncovers vicious scratch-itch cycle
New research uncovers vicious scratch-itch cycleScratching results in the brain’s release of serotonin, intensifying the itch sensation, according to results of a recent animal study. Understanding how to better control the cycle could lead to less itching, especially in those suffering from chronic itching.